Jefferies Group LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Jefferies Group LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,842,478
+66.5%
47,050
+37.4%
0.02%
+66.7%
Q2 2022$1,106,275
+13.3%
34,250
+16.1%
0.01%
+50.0%
Q1 2022$976,450
+33.4%
29,500
+71.5%
0.01%
+50.0%
Q4 2021$731,943
+81.5%
17,206
+89.1%
0.00%
+33.3%
Q3 2021$403,221
-91.7%
9,100
-89.3%
0.00%
-90.3%
Q2 2021$4,844,644
-46.6%
85,278
-29.7%
0.03%
-60.8%
Q1 2021$9,079,305
+22.9%
121,300
+42.0%
0.08%
+38.6%
Q4 2020$7,387,954
+92.7%
85,400
+36.2%
0.06%
+32.6%
Q3 2020$3,833,000
+163.4%
62,700
+79.1%
0.04%
+152.9%
Q2 2020$1,455,000
+388.3%
35,000
+237.7%
0.02%
+466.7%
Q1 2020$298,000
-97.8%
10,365
-94.6%
0.00%
-97.2%
Q4 2019$13,754,000
-32.7%
190,518
+30.8%
0.11%
-32.3%
Q3 2019$20,430,000
-24.9%
145,624
-2.0%
0.16%
-20.2%
Q2 2019$27,213,000
+3.6%
148,629
-10.0%
0.20%
-8.3%
Q1 2019$26,275,000
+264.5%
165,200
+119.5%
0.22%
+266.1%
Q4 2018$7,208,000
+118.1%
75,253
+81.3%
0.06%
+168.2%
Q2 2017$3,305,000
+287.5%
41,500
+245.8%
0.02%
+266.7%
Q1 2017$853,000
-79.9%
12,000
-87.0%
0.01%
-72.7%
Q3 2016$4,247,000
-83.4%
92,226
-89.2%
0.02%
-81.2%
Q2 2016$25,626,000
+11601.4%
850,510
+28250.3%
0.12%
+11600.0%
Q2 2015$219,0003,0000.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders